Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AHR✓SelectedUSD · AHRGSK vs AHR performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs AHR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.6%
AHR return
+16.5%
Excess return
-21.2%
Maximum drawdown
-13.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioAHRExcessAlpha
1D-1.6%-1.6%0.0%-1.0%
7D-4.7%-1.8%-3.0%-4.1%
30D-4.7%+6.0%-10.7%-6.5%
3M-8.8%+4.9%-13.6%-10.1%
6M-4.6%+14.5%-19.1%-7.7%
All-4.6%+16.5%-21.2%-7.7%

Cumulative growth

Daily Returns

Daily percentage return beside AHR.

Daily Out/Under-Performance

Portfolio return minus AHR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AHR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded AHR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling